Graves' Disease with Thymic Hyperplasia: The Response of the Thyroid Function, Thyrotropin Receptor Autoantibody, and Thymic Size to Thiamazole Treatment

Autor:	Daichi, Tsukada, Katsumi, Iizuka, Ken, Takao, Yanyan, Liu, Sodai, Kubota, Saki, Okamoto-Kubota, Teruaki, Sakurai, Toshinori, Imaizumi, Mayu, Sakai, Takehiro, Kato, Masami, Mizuno, Takuo, Hirota, Tetsuya, Suwa, Yukio, Horikawa, Mayumi, Yamamoto, Sumihisa, Kubota, Daisuke, Yabe
Rok vydání:	2022
Předmět:	Adult Young Adult Methimazole Internal Medicine Humans Thyrotropin Female Receptors Thyrotropin Thymus Hyperplasia General Medicine Graves Disease Autoantibodies
Zdroj:	Internal Medicine. 61:2753-2757
ISSN:	1349-7235 0918-2918
Popis:	We treated a 22-year-old woman suffering from Graves' disease and thymic hyperplasia. She was referred to our institution for a close investigation of thyrotoxicosis and thymic mass. Thyroid tests and magnetic resonance imaging resulted in a diagnosis of Graves' disease and thymic hyperplasia. The thyroid function and thyroid-stimulating hormone receptor antibody (TRAb) were normalized one and five months after thiamazole initiation, respectively. The thymic size began to decrease after 1 month and was further decreased after 5 months; it was normalized after 12 months. The correlation between TRAb titers and the thymic size (R
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34cf33c05450c2fe03e85369f51c7c46 https://doi.org/10.2169/internalmedicine.8710-21 Zobrazit plný text záznamu